6533b7cffe1ef96bd12586fb

RESEARCH PRODUCT

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

Nicola CascavillaMonica GalliMario BoccadoroDominella GangemiSilvia MangiacavalliMassimo OffidaniAnna Grazia RecchiaElena ZamagniAngelo BelottiAlessandra PompaClaudio CerchioneGiuseppina UccelloPaola CurciCatello CalifanoConcetta ConticelloElena RossiMaria Teresa PetrucciValerio De StefanoGiovanni TripepiUgo ConsoliEnrico AttingentiMarino BrunoriStelvio BallantiClelia CriscuoloNicola GiulianiMichele CavoRenato ZambelloVincenzo Ludovico FraticelliGiorgina SpecchiaAngela BonalumiFrancesca PatriarcaNicola Di RenzoAlessandra LombardoSalvatore PalmieriElisabetta AntonioliCirino BottaAgostina SiniscalchiRaffaella StocchiBarbara GamberiFerdinando FrigeriMassimo GentileGiuseppe MeleErnesto VignaPellegrino MustoDonatella VincelliSilvana CapalboAnnalisa PitinoSara BringhenDaniele DerudasFrancesco Di RaimondoMassimo MartinoRoberto RiaAlfredo GagliardiGianpaolo MarcacciFortunato MorabitoStefano Rocco

subject

Oncologymedicine.medical_specialtyElotuzumab lenalidomide dexamethasone salvage therapy multiple myelomaSalvage therapyAntibodies Monoclonal HumanizedAntibodiesDexamethasoneEfficacyInternal medicineMonoclonalAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProgression-free survivalElotuzumabLetters to the EditorElotuzumab lenalidomide dexamethasone multiple myelomaHumanizedLenalidomideMultiple myelomaRetrospective StudiesLenalidomideSalvage Therapybusiness.industryRetrospective cohort studyHematologymedicine.diseaseClinical trialItalyAntibodies Monoclonal Humanized; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Humans; Italy; Lenalidomide; Retrospective Studies; Salvage Therapy; Multiple MyelomaMultiple Myelomabusinessmedicine.drug

description

No abstract available

10.3324/haematol.2019.241513http://hdl.handle.net/11390/1197358